Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr₹107 Cr

What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Non-Current Liabilities ratio of MANKIND PHARMA is ₹7,420 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹7,420 Cr
Mar2024₹187 Cr
Mar2023₹199 Cr
Mar2022₹169 Cr
Mar2021₹107 Cr

How is Total Non-Current Liabilities of MANKIND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹7,420 Cr
3,860.66
Mar2024 ₹187 Cr
-5.97
Mar2023 ₹199 Cr
18.12
Mar2022 ₹169 Cr
57.15
Mar2021 ₹107 Cr -

Compare Total Non-Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,575.6 Cr 5.8% 13.4% -11.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹388,680.0 Cr -2.9% -8.9% -3.7% Stock Analytics
DIVIS LABORATORIES ₹168,817.0 Cr 1.2% 4.2% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,297.0 Cr -1.7% -3.6% 27.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,828.0 Cr 6.8% 1.3% 13.2% Stock Analytics
CIPLA ₹104,588.0 Cr 5.4% 3.1% -13.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

5.8%

13.4%

-11.3%

SENSEX

-2.3%

3.3%

-2.4%


You may also like the below Video Courses